MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
6.42
-0.30 (-4.46%)
At close: Jul 18, 2025, 4:00 PM
6.43
+0.01 (0.16%)
After-hours: Jul 18, 2025, 5:05 PM EDT
MiMedx Group Stock Forecast
Stock Price Forecast
The 2 analysts that cover MiMedx Group stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 79.13% increase in the stock price over the next year. The lowest target is $11 and the highest is $12.
Price Target: $11.5 (+79.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +71.34% | Jul 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $13 | Buy | Reiterates | $13 | +102.49% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +71.34% | Aug 1, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +86.92% | Aug 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +71.34% | Jul 2, 2024 |
Financial Forecast
Revenue This Year
382.21M
from 348.88M
Increased by 9.55%
Revenue Next Year
425.89M
from 382.21M
Increased by 11.43%
EPS This Year
0.26
from 0.28
Decreased by -8.94%
EPS Next Year
0.34
from 0.26
Increased by 30.69%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 395.0M | 451.5M | 484.5M |
| Avg | 382.2M | 425.9M | 470.6M |
| Low | 366.5M | 398.6M | 452.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 13.2% | 18.1% | 13.8% |
| Avg | 9.6% | 11.4% | 10.5% |
| Low | 5.1% | 4.3% | 6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.29 | 0.40 | 0.38 |
| Avg | 0.26 | 0.34 | 0.37 |
| Low | 0.22 | 0.29 | 0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.0% | 54.9% | 12.3% |
| Avg | -8.9% | 30.7% | 9.1% |
| Low | -23.8% | 14.2% | 4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.